Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 26.06.2026 UNCU.LN IE00BD6GCF16 869,511.00 USD 41,652,942.79 47.904  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 26.06.2026 UINC IE00BZBW4Z27 10,237,316.00 USD 405,202,354.28 39.581  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 26.06.2026 FPX. IE00BYTH6238 250,002.00 USD 18,295,128.80 73.180  ...
-

D’Abou Dhabi à Imola : A2RL poursuit son expansion internationale avec une première historique en course autonome sur le légendaire circuit italien

IMOLA, Italie--(BUSINESS WIRE)--L’Abu Dhabi Autonomous Racing League (A2RL) effectuera ses débuts internationaux en compétition le 5 septembre 2026 à Imola, en Italie, en engageant jusqu’à cinq voitures de course entièrement autonomes basées sur la Dallara Super Formula SF23 sur l’un des circuits les plus emblématiques et les plus exigeants au monde. Organisée par ASPIRE, la branche « grands défis » de l’Advanced Technology Research Council d’Abou Dhabi, A2RL est rapidement passée d’une platefo...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 26.06.2026 GINC LN IE00BD842Y21 906,166.00 USD 56,769,268.17 62.648  ...
-

Niobrara Capital Announces Strategic Partnership with WovenLight to Accelerate AI-Driven Value Creation

NEW YORK--(BUSINESS WIRE)--Niobrara Capital ("Niobrara"), a U.S. based private equity firm focused on investing in middle-market B2B technology and technology-enabled services companies, today announced a strategic partnership with WovenLight, a firm purpose-built to transform performance in private equity portfolio companies through data science and artificial intelligence. The partnership reflects Niobrara's strategy of tech-enabled investment in technology companies and its belief that AI wi...
-

Almonty Industries Joins Large-Cap Russell 1000® Index and Broad-Market Russell 3000® Index

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it has joined the large-cap Russell 1000® Index and the broad-market Russell 3000® Index, effective with the opening of United States equity markets today, Monday, June 29, 2026, upon the conclusion of the 2026 Russell indexes reconstitution. The June 2026 reconstitution of the Russell...
-

Valmont Releases 2026 Sustainability Report

OMAHA, Neb.--(BUSINESS WIRE)--Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today released its 2026 Sustainability Report. "At Valmont, sustainability is embedded in the way we serve our customers and communities around the world," said Avner Applbaum, President and CEO. “Every day, our teams help strengthen critical infrastructure, support agricultural productivity, and design s...
-

Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced several tibulizumab program updates. Zura has completed enrollment of the Phase 2 TibuSHIELD trial of tibulizumab in adults with HS. The TibuSHIELD trial exceeded the target enrollment, with 247 participants...
-

Northisle Announces Results of Annual General Meeting

VANCOUVER, British Columbia--(BUSINESS WIRE)--Northisle is pleased to announce the results of its Annual General Meeting....